Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of赞助的临床试验
总计738个结果
-
Funan LiuInstitute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese... 和其他合作者招聘中
-
Funan LiuInstitute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese... 和其他合作者招聘中
-
Cancer Institute and Hospital, Chinese Academy...Beijing Municipal Science & Technology Commission主动，不招人三阴性乳腺癌
-
Cancer Institute and Hospital, Chinese Academy...Beijing Municipal Science & Technology Commission未知
-
Academy Military Medical Science, ChinaCancer Institute and Hospital, Chinese Academy of Medical Sciences未知
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中化疗毒性 | 放射治疗；并发症 | PARP抑制剂 | 免疫检查点抑制剂 | 曲妥珠单抗 | 乳腺癌，家族性男性 | CDK4/6 抑制剂 | 帕妥珠单抗中国
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...招聘中贝伐单抗 | 卡培他滨 | 转移性结直肠癌 (mCRC) | 奥沙利铂 | 替雷利珠单抗 | 第一行 | MSS/pMMR | RAS突变中国
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...招聘中